Leveraging The Interface Between Epidemiology And Molecular Biology To Enhance Disease Prevention
Funder
National Health and Medical Research Council
Funding Amount
$1,850,925.00
Summary
Some diseases are becoming more common over time.The increase over time is too rapid to be due to genetics alone. My research program aims to identify the environmental drivers of these diseases so that we can improve the current efforts to stop these diseases before they even begin. The research program has a focus on factors impacting on how a child's brain develops, how food allergy begins and the factors that can prevent multiple sclerosis onset or slow progression.
Multi-dimensional Monitoring Of Cognition And Cerebellar Function To Prospectively Define Disease Progression In Multiple Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$1,462,250.00
Summary
Multiple Sclerosis (MS) is an autoimmune degenerative brain disease that cost Australia >$1.7 billion/year in lost productivity. An estimated 50% of people with MS (pwMS) develop unrelenting, progressive disability (secondary progressive MS, SPMS). SPMS is currently diagnosed retrospectively by observing inexorable worsening in neurological function without relapses for > 6 month
Revolutionising Multiple Sclerosis Care And Trials Through E-health
Funder
National Health and Medical Research Council
Funding Amount
$2,182,124.00
Summary
Multiple Sclerosis (MS) is now a highly treatable disease. However, many people with MS are not treated optimally because health care delivery is intermittent and disease monitoring is patchy. People failing treatment should switch quickly to prevent disability, but the treatment choices and sequences also need to be safe long-term. The solution to these problems, to be validated by my team, is greater involvement of people with MS in their own monitoring though e-health tools.